{
  "actions": [
    {
      "acted_at": "2014-12-08", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2014-12-12", 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5805-113", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "113", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2014-12-08", 
  "number": "5805", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to expanding access for breakthrough drugs, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Andrea Sloan Compassionate Use Reform and Enhancement Act", 
  "sponsor": {
    "district": "10", 
    "name": "McCaul, Michael T.", 
    "state": "TX", 
    "thomas_id": "01804", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2014-12-08", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Administrative remedies", 
    "Advisory bodies", 
    "Congressional oversight", 
    "Consumer affairs", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug therapy", 
    "Executive agency funding and structure", 
    "Food and Drug Administration (FDA)", 
    "Government information and archives", 
    "Government studies and investigations", 
    "Health", 
    "Health care coverage and access"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Andrea Sloan Compassionate Use Reform and Enhancement Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Andrea Sloan CURE Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to expanding access for breakthrough drugs, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2015-09-01T10:21:06-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d113:HR5805:@@@L&summ2=m&"
}